90 related articles for article (PubMed ID: 11156379)
21. Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.
Bashir O; Fitzgerald AJ; Berlanga-Acosta J; Playford RJ; Goodlad RA
Clin Sci (Lond); 2003 Sep; 105(3):323-30. PubMed ID: 12749762
[TBL] [Abstract][Full Text] [Related]
22. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
23. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
24. o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis.
Sills RC; Hong HL; Flake G; Moomaw C; Clayton N; Boorman GA; Dunnick J; Devereux TR
Carcinogenesis; 2004 Apr; 25(4):605-12. PubMed ID: 14688030
[TBL] [Abstract][Full Text] [Related]
25. Supplementation with phytoestrogens and insoluble fibers reduces intestinal carcinogenesis and restores ER-β expression in Apc-driven colorectal carcinogenesis.
Luceri C; Femia AP; Tortora K; D'Ambrosio M; Fabbri S; Fazi M; Caderni G
Eur J Cancer Prev; 2020 Jan; 29(1):27-35. PubMed ID: 31651566
[TBL] [Abstract][Full Text] [Related]
26. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
[TBL] [Abstract][Full Text] [Related]
27. Reduction of N-methyl-N-nitrosourea-induced colon tumors in the rat by cholesterol.
Cohen BI; Raicht RF; Fazzini E
Cancer Res; 1982 Dec; 42(12):5050-2. PubMed ID: 7139609
[TBL] [Abstract][Full Text] [Related]
28. Spectral markers in preneoplastic intestinal mucosa: an accurate predictor of tumor risk in the MIN mouse.
Roy HK; Kim YL; Wali RK; Liu Y; Koetsier J; Kunte DP; Goldberg MJ; Backman V
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1639-45. PubMed ID: 16030095
[TBL] [Abstract][Full Text] [Related]
29. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
30. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
[TBL] [Abstract][Full Text] [Related]
31. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
33. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
[TBL] [Abstract][Full Text] [Related]
34. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer.
Amos-Landgraf JM; Kwong LN; Kendziorski CM; Reichelderfer M; Torrealba J; Weichert J; Haag JD; Chen KS; Waller JL; Gould MN; Dove WF
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4036-41. PubMed ID: 17360473
[TBL] [Abstract][Full Text] [Related]
35. beta-Catenin-accumulated crypts in the colonic mucosa of juvenile ApcMin/+ mice.
Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Yamada Y; Oyama T; Kuno T; Hirose Y; Hara A; Mori H
Cancer Lett; 2006 Jul; 239(1):123-8. PubMed ID: 16168560
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
37. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M
Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779
[TBL] [Abstract][Full Text] [Related]
38. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats.
Dolara P; Luceri C; De Filippo C; Femia AP; Giovannelli L; Caderni G; Cecchini C; Silvi S; Orpianesi C; Cresci A
Mutat Res; 2005 Dec; 591(1-2):237-46. PubMed ID: 16293270
[TBL] [Abstract][Full Text] [Related]
39. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.
Huerta S; Irwin RW; Heber D; Go VL; Koeffler HP; Uskokovic MR; Harris DM
Cancer Res; 2002 Feb; 62(3):741-6. PubMed ID: 11830528
[TBL] [Abstract][Full Text] [Related]
40. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.
Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G
Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
